COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?

被引:0
作者
T. Filardi
S. Morano
机构
[1] Policlinico Umberto I,Department of Experimental Medicine
[2] “Sapienza” University of Rome,undefined
来源
Journal of Endocrinological Investigation | 2020年 / 43卷
关键词
COVID-19; SARS-CoV-2; Diabetes; ACE2; DPP4; Diabetes therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1053 / 1060
页数:7
相关论文
共 491 条
[1]  
Xu XW(2020)Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series BMJ 368 m606-129
[2]  
Wu XX(2020)Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Front Med 13 121-158
[3]  
Jiang XG(2020)Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy JAMA 4 148-869
[4]  
Xu KJ(2020)Demographic and clinical factors associated with development of type 2 diabetes: a review of the literature Int J Gen Med 43 867-201
[5]  
Ying LJ(2016)Diabetes and infection: assessing the association with glycaemic control in population-based studies Lancet Diabetes Endocrinol 18 187-265
[6]  
Ma CL(2020)Prevalence and impact of diabetes among people infected with SARS-CoV-2 J Endocrinol Invest 26 259-2410
[7]  
Li SB(2020)Clinical characteristics and outcomes of patients with severe covid-19 with diabetes BMJ Open Diabetes Res Care 107 154216-2899
[8]  
Wang HY(1992)Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections Diabete Metab 32 2401-252
[9]  
Zhang S(1999)Immune dysfunction in patients with diabetes mellitus (DM) FEMS Immunol Med Microbiol 29 2890-246
[10]  
Gao HN(2020)COVID-19-Related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure Thromb Haemost 11 242-570